OMB
.report
Search
DTBE/FSB Rifampin (RIF) Email Assessment
Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCHHSTP)
OMB: 0920-1027
IC ID: 244515
OMB.report
HHS/CDC
OMB 0920-1027
ICR 202005-0920-010
IC 244515
( )
⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0920-1027 can be found here:
2023-05-11 - Extension without change of a currently approved collection
Documents and Forms
Document Name
Document Type
Att 1 RIF Followup Survey.docx
Other-WORD
Customer Service GenIC Clearance Template_Rif Assessment.docx
Request for Approval
IC Document
Information Collection (IC) Details
View Information Collection (IC)
IC Title:
DTBE/FSB Rifampin (RIF) Email Assessment
Agency IC Tracking Number:
0920-1027-21AX
IC Status:
New
Obligation to Respond:
Voluntary
CFR Citation:
Information Collection Instruments:
Document Type
Form No.
Form Name
Instrument File
URL
Available Electronically?
Can Be Submitted Electronically?
Electronic Capability
Other-WORD
Att 1 RIF Followup Survey.docx
No
Fillable Printable
Federal Enterprise Architecture Business Reference Module
Line of Business:
Health
Subfunction:
Public Health Monitoring
Privacy Act System of Records
Title:
FR Citation:
Number of Respondents:
61
Number of Respondents for Small Entity:
0
Affected Public:
State, Local, and Tribal Governments
Percentage of Respondents Reporting Electronically:
0 %
Approved
Program Change Due to New Statute
Program Change Due to Agency Discretion
Change Due to Adjustment in Agency Estimate
Change Due to Potential Violation of the PRA
Previously Approved
Annual Number of Responses for this IC
122
0
122
0
0
0
Annual IC Time Burden (Hours)
122
0
122
0
0
0
Annual IC Cost Burden (Dollars)
0
0
0
0
0
0
Documents for IC
Title
Document
Date Uploaded
Request for Approval
Customer Service GenIC Clearance Template_Rif Assessment.docx
11/15/2020
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.